You are here

  • Home
  • Archive
  • Volume 96, Issue 11
  • Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

Article info

Article menu
Download PDFPDF
Acute coronary syndromes
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

Authors

  1. Correspondence to Dr Kent R Nilsson, Jr, Division of Cardiology, Department of Medicine, Duke University Medical Center, Erwin Road, DUMC 31009, Durham, NC 27710, USA; kent.nilsson{at}duke.edu
View Full Text

Citation

Nilsson KR, Al-Khatib SM, Zhou Y, et al
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Heart 2010;96:838-842.

Publication history

  • Accepted January 25, 2010
  • First published April 20, 2010.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.